The Role of Arterial Elasticity in Determining the Degree of Chronic Heart Failure in Myocardial Infarction

Aim      To study the left ventricular (LV) contractile and pumping function during the recovery phase following ligation of the anterior descending coronary artery (CA).

Material and methods  Cardiodynamic parameters were studied in Wistar rats 2-4 weeks after experimental myocardial infarction (MI). MI was induced by ligation of the anterior descending CA under zoletil anesthesia. LV catheterization was performed with a standard FTH-1912B-8018 PV catheter inserted into the LV through the right carotid artery.

Results After the induction of MI, the mortality rate of animals was 50%. Survived animals developed significant LV dilatation and a decrease in ejection fraction (EF) by an average of 31%. However, major indexes of the pumping function, including minute volume, heart work, and maximum ejection velocity, were within a normal range whereas the maximum filling velocity was almost doubled. Approximately 50% of hearts with dilated LV had normal EF, delayed relaxation, and increased LV diastolic pressure, which qualified this group as a diastolic dysfunction group. The systolic dysfunction group with EF less than 50% of normal had similar values of myocardial contractility and relaxation but differed from the diastolic dysfunction group in more than 50% reduced maximum LV ejection velocity and 1.7 times increased elasticity of the arterial wall. A close inverse correlation was found between these values (r= -0.91).

Conclusion      The study results showed that, with a similar myocardial contractile function, the cardiac pumping function is determined by the elasticity of the aortic wall. Therefore, restriction of reactive fibrosis during MI is an important task of modern cardiology.

1. Onai Y, Suzuki J, Maejima Y, Haraguchi G, Muto S, Itai A et al. Inhibition of NF-κB improves left ventricular remodeling and cardiac dysfunction after myocardial infarction. American Journal of Physiology-Heart and Circulatory Physiology. 2007;292(1):H530–8. DOI: 10.1152/ajpheart.00549.2006

2. Piątek-Matuszak P, Pasławski R, Pasławska U, Kiczak L, Płóciennik M, Janiszewski A et al. Assessment of Myocardial Diastolic Dysfunction as a Result of Myocardial Infarction and Extracellular Matrix Regulation Disorders in the Context of Mesenchymal Stem Cell Therapy. Journal of Clinical Medicine. 2022;11(18):5430. DOI: 10.3390/jcm11185430

3. Sjöblom J, Muhrbeck J, Witt N, Alam M, Frykman-Kull V. Evolution of Left Ventricular Ejection Fraction After Acute Myocardial Infarction: Implications for Implantable Cardioverter-Defibrillator Eligibility. Circulation. 2014;130(9):743–8. DOI: 10.1161/CIRCULATIONAHA.114.009924

4. Gonçalves AF, Congio LH, Dos Santos PP, Rafacho BPM, Pereira BLB, Claro RFT et al. Pamidronate Attenuates Diastolic Dysfunction Induced by Myocardial Infarction Associated with Changes in Geometric Patterning. Cellular Physiology and Biochemistry. 2015;35(1):259–69. DOI: 10.1159/000369693

5. Gerber Y, Weston SA, Berardi C, McNallan SM, Jiang R, Redfield MM et al. Contemporary Trends in Heart Failure With Reduced and Preserved Ejection Fraction After Myocardial Infarction: A Community Study. American Journal of Epidemiology. 2013;178(8):1272–80. DOI: 10.1093/aje/kwt109

6. Eskander M, Kern MJ. Invasive Hemodynamics of Myocardial Disease: Systolic and Diastolic Dysfunction (and Hypertrophic Obstructive Cardiomyopathy). Interventional Cardiology Clinics. 2017;6(3):297–307. DOI: 10.1016/j.iccl.2017.03.001

7. Sanderson JE. Heart failure with a normal ejection fraction. Heart. 2005;93(2):155–8. DOI: 10.1136/hrt.2005.074187

8. Connelly KA, Zhang Y, Desjardins J-F, Nghiem L, Visram A, Batchu SN et al. Load-independent effects of empagliflozin contribute to improved cardiac function in experimental heart failure with reduced ejection fraction. Cardiovascular Diabetology. 2020;19(1):13. DOI: 10.1186/s12933-020-0994-y

9. Tulacz D, Mackiewicz U, Maczewski M, Maciejak A, Gora M, Burzynska B. Transcriptional profiling of left ventricle and peripheral blood mononuclear cells in a rat model of postinfarction heart failure. BMC Medical Genomics. 2013;6(1):49. DOI: 10.1186/1755-8794-6-49

10. Tomoaia R, Beyer RS, Simu G, Serban AM, Pop D. Understanding the role of echocardiography in remodeling after acute myocardial infarction and development of heart failure with preserved ejection fraction. Medical Ultrasonography. 2019;21(1):69–76. DOI: 10.11152/mu-1768

11. Asai H, Shingu Y, Yamakawa T, Niwano H, Wakasa S, Ooka T et al. Left-Ventricular Plication Reduces Wall Stress and Cardiomyocyte Hypertrophy in a Rat Model of Ischemic Cardiomyopathy. European Surgical Research. 2017;58(1–2):69–80. DOI: 10.1159/000452682

12. Wittig C, Szulcek R. Extracellular Matrix Protein Ratios in the Human Heart and Vessels: How to Distinguish Pathological From Physiological Changes? Frontiers in Physiology. 2021;12:708656. DOI: 10.3389/fphys.2021.708656

13. Kong CH, Lin XY, Woo CC, Wong HC, Lee CN, Richards AM et al. Characteristics of aortic wall extracellular matrix in patients with acute myocardial infarction: tissue microarray detection of collagen I, collagen III and elastin levels. Interactive CardioVascular and Thoracic Surgery. 2013;16(1):11–5. DOI: 10.1093/icvts/ivs421

14. Zhuge Y, Zhang J, Qian F, Wen Z, Niu C, Xu K et al. Role of smooth muscle cells in Cardiovascular Disease. International Journal of Biological Sciences. 2020;16(14):2741–51. DOI: 10.7150/ijbs.49871

15. Raij L, Gonzalez-Ochoa AM. Vascular compliance in blood pressure. Current Opinion in Nephrology & Hypertension. 2011;20(5):457–64. DOI: 10.1097/MNH.0b013e3283499d7b

16. Laurent S, Boutouyrie P. Arterial stiffness: a new surrogate end point for cardiovascular disease? Journal of Nephrology. 2007;20(Suppl 12):S45-50. PMID: 18050143

17. Schimmel K, Ichimura K, Reddy S, Haddad F, Spiekerkoetter E. Cardiac Fibrosis in the Pressure Overloaded Left and Right Ventricle as a Therapeutic Target. Frontiers in Cardiovascular Medicine. 2022;9:886553. DOI: 10.3389/fcvm.2022.886553

18. Ageev F.T., Ovchinnikov A.G. Diastolic heart failure: 20 years later. Сurrent issues of pathoge nesis, diagnosis and treatment of heart failure with preserved LVEF. Kardiologiia. 2023;63(3):3–12. DOI: 10.18087/cardio.2023.3.n2376